Webinar on Results of XPro in AD Showing Improvements in White Matter Pathology and Decrease in PTau

White Matter Damage Increases the Risk of Alzheimer's Disease

XPro1595 Webinar on Expanded Phase 1b Data in Patients with Alzheimer’s Disease

Webinar on XPro1595 Phase Ib Interim Data of Neuroinflammation in Patients with Alzheimer's Disease

INB03 / XPro1595 Mechanism of Action

Have a Question?
858 964 3720
Email Us
dmoss@inmunebio.com
Opening Hours
M - F 8am to 5pm PST